Report Detail
Global Rapid-dissolving Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM3693753 |
- 13 August, 2024 |
- Global |
- 117 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Rapid-dissolving Tablets market size was valued at USD 15760 million in 2023 and is forecast to a readjusted size of USD 33130 million by 2030 with a CAGR of 11.2% during review period.
Rapid-dissolving Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The orodispersible tablets market is driven by the increasing demand for patient-friendly and convenient drug delivery systems and the growing focus on improving medication adherence. Orodispersible tablets, also known as orally disintegrating tablets or melt-in-mouth tablets, are designed to dissolve rapidly in the mouth without the need for water, making them easier to swallow, especially for patients who have difficulty swallowing conventional tablets or capsules. The rise in the aging population and the prevalence of chronic diseases contribute to market growth, as these patient populations often face challenges in taking oral medications. Moreover, advancements in formulation technology and taste-masking techniques have improved the palatability and acceptance of orodispersible tablets. However, the market also faces challenges, including the cost of development and manufacturing of specialized formulations and addressing stability and shelf-life concerns. Additionally, obtaining regulatory approvals and ensuring consistent quality and performance can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer a diverse range of orodispersible tablet formulations, collaborate with healthcare providers to address specific patient needs, and address the challenges to meet the increasing demand for patient-friendly and effective drug delivery solutions.
The Global Info Research report includes an overview of the development of the Rapid-dissolving Tablets industry chain, the market status of CNS Diseases (Anti-Psychotics Drug, Anti-Epileptics Drug), Gastrointestinal Diseases (Anti-Psychotics Drug, Anti-Epileptics Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rapid-dissolving Tablets.
Regionally, the report analyzes the Rapid-dissolving Tablets markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rapid-dissolving Tablets market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rapid-dissolving Tablets market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rapid-dissolving Tablets industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Anti-Psychotics Drug, Anti-Epileptics Drug).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rapid-dissolving Tablets market.
Regional Analysis: The report involves examining the Rapid-dissolving Tablets market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rapid-dissolving Tablets market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rapid-dissolving Tablets:
Company Analysis: Report covers individual Rapid-dissolving Tablets manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rapid-dissolving Tablets This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (CNS Diseases, Gastrointestinal Diseases).
Technology Analysis: Report covers specific technologies relevant to Rapid-dissolving Tablets. It assesses the current state, advancements, and potential future developments in Rapid-dissolving Tablets areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rapid-dissolving Tablets market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rapid-dissolving Tablets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Market segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Major players covered
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rapid-dissolving Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rapid-dissolving Tablets, with price, sales, revenue and global market share of Rapid-dissolving Tablets from 2019 to 2024.
Chapter 3, the Rapid-dissolving Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rapid-dissolving Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rapid-dissolving Tablets market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rapid-dissolving Tablets.
Chapter 14 and 15, to describe Rapid-dissolving Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Rapid-dissolving Tablets
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Rapid-dissolving Tablets Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Anti-Psychotics Drug
- 1.3.3 Anti-Epileptics Drug
- 1.3.4 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Rapid-dissolving Tablets Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 CNS Diseases
- 1.4.3 Gastrointestinal Diseases
- 1.4.4 CVS Diseases
- 1.4.5 Other
- 1.5 Global Rapid-dissolving Tablets Market Size & Forecast
- 1.5.1 Global Rapid-dissolving Tablets Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Rapid-dissolving Tablets Sales Quantity (2019-2030)
- 1.5.3 Global Rapid-dissolving Tablets Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Teva
- 2.1.1 Teva Details
- 2.1.2 Teva Major Business
- 2.1.3 Teva Rapid-dissolving Tablets Product and Services
- 2.1.4 Teva Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Teva Recent Developments/Updates
- 2.2 Merck
- 2.2.1 Merck Details
- 2.2.2 Merck Major Business
- 2.2.3 Merck Rapid-dissolving Tablets Product and Services
- 2.2.4 Merck Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Merck Recent Developments/Updates
- 2.3 Mylan
- 2.3.1 Mylan Details
- 2.3.2 Mylan Major Business
- 2.3.3 Mylan Rapid-dissolving Tablets Product and Services
- 2.3.4 Mylan Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Mylan Recent Developments/Updates
- 2.4 Pfizer
- 2.4.1 Pfizer Details
- 2.4.2 Pfizer Major Business
- 2.4.3 Pfizer Rapid-dissolving Tablets Product and Services
- 2.4.4 Pfizer Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Pfizer Recent Developments/Updates
- 2.5 Johnson and Johnson
- 2.5.1 Johnson and Johnson Details
- 2.5.2 Johnson and Johnson Major Business
- 2.5.3 Johnson and Johnson Rapid-dissolving Tablets Product and Services
- 2.5.4 Johnson and Johnson Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Johnson and Johnson Recent Developments/Updates
- 2.6 GSK
- 2.6.1 GSK Details
- 2.6.2 GSK Major Business
- 2.6.3 GSK Rapid-dissolving Tablets Product and Services
- 2.6.4 GSK Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 GSK Recent Developments/Updates
- 2.7 Otsuka
- 2.7.1 Otsuka Details
- 2.7.2 Otsuka Major Business
- 2.7.3 Otsuka Rapid-dissolving Tablets Product and Services
- 2.7.4 Otsuka Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Otsuka Recent Developments/Updates
- 2.8 Eli Lilly and Company
- 2.8.1 Eli Lilly and Company Details
- 2.8.2 Eli Lilly and Company Major Business
- 2.8.3 Eli Lilly and Company Rapid-dissolving Tablets Product and Services
- 2.8.4 Eli Lilly and Company Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Eli Lilly and Company Recent Developments/Updates
- 2.9 AstraZeneca
- 2.9.1 AstraZeneca Details
- 2.9.2 AstraZeneca Major Business
- 2.9.3 AstraZeneca Rapid-dissolving Tablets Product and Services
- 2.9.4 AstraZeneca Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 AstraZeneca Recent Developments/Updates
- 2.10 Bristol-Myers Squibb
- 2.10.1 Bristol-Myers Squibb Details
- 2.10.2 Bristol-Myers Squibb Major Business
- 2.10.3 Bristol-Myers Squibb Rapid-dissolving Tablets Product and Services
- 2.10.4 Bristol-Myers Squibb Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Bristol-Myers Squibb Recent Developments/Updates
- 2.11 Conquer
- 2.11.1 Conquer Details
- 2.11.2 Conquer Major Business
- 2.11.3 Conquer Rapid-dissolving Tablets Product and Services
- 2.11.4 Conquer Rapid-dissolving Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Conquer Recent Developments/Updates
3 Competitive Environment: Rapid-dissolving Tablets by Manufacturer
- 3.1 Global Rapid-dissolving Tablets Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Rapid-dissolving Tablets Revenue by Manufacturer (2019-2024)
- 3.3 Global Rapid-dissolving Tablets Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Rapid-dissolving Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Rapid-dissolving Tablets Manufacturer Market Share in 2023
- 3.4.2 Top 6 Rapid-dissolving Tablets Manufacturer Market Share in 2023
- 3.5 Rapid-dissolving Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Rapid-dissolving Tablets Market: Region Footprint
- 3.5.2 Rapid-dissolving Tablets Market: Company Product Type Footprint
- 3.5.3 Rapid-dissolving Tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Rapid-dissolving Tablets Market Size by Region
- 4.1.1 Global Rapid-dissolving Tablets Sales Quantity by Region (2019-2030)
- 4.1.2 Global Rapid-dissolving Tablets Consumption Value by Region (2019-2030)
- 4.1.3 Global Rapid-dissolving Tablets Average Price by Region (2019-2030)
- 4.2 North America Rapid-dissolving Tablets Consumption Value (2019-2030)
- 4.3 Europe Rapid-dissolving Tablets Consumption Value (2019-2030)
- 4.4 Asia-Pacific Rapid-dissolving Tablets Consumption Value (2019-2030)
- 4.5 South America Rapid-dissolving Tablets Consumption Value (2019-2030)
- 4.6 Middle East and Africa Rapid-dissolving Tablets Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Rapid-dissolving Tablets Sales Quantity by Type (2019-2030)
- 5.2 Global Rapid-dissolving Tablets Consumption Value by Type (2019-2030)
- 5.3 Global Rapid-dissolving Tablets Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Rapid-dissolving Tablets Sales Quantity by Application (2019-2030)
- 6.2 Global Rapid-dissolving Tablets Consumption Value by Application (2019-2030)
- 6.3 Global Rapid-dissolving Tablets Average Price by Application (2019-2030)
7 North America
- 7.1 North America Rapid-dissolving Tablets Sales Quantity by Type (2019-2030)
- 7.2 North America Rapid-dissolving Tablets Sales Quantity by Application (2019-2030)
- 7.3 North America Rapid-dissolving Tablets Market Size by Country
- 7.3.1 North America Rapid-dissolving Tablets Sales Quantity by Country (2019-2030)
- 7.3.2 North America Rapid-dissolving Tablets Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Rapid-dissolving Tablets Sales Quantity by Type (2019-2030)
- 8.2 Europe Rapid-dissolving Tablets Sales Quantity by Application (2019-2030)
- 8.3 Europe Rapid-dissolving Tablets Market Size by Country
- 8.3.1 Europe Rapid-dissolving Tablets Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Rapid-dissolving Tablets Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Rapid-dissolving Tablets Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Rapid-dissolving Tablets Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Rapid-dissolving Tablets Market Size by Region
- 9.3.1 Asia-Pacific Rapid-dissolving Tablets Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Rapid-dissolving Tablets Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Rapid-dissolving Tablets Sales Quantity by Type (2019-2030)
- 10.2 South America Rapid-dissolving Tablets Sales Quantity by Application (2019-2030)
- 10.3 South America Rapid-dissolving Tablets Market Size by Country
- 10.3.1 South America Rapid-dissolving Tablets Sales Quantity by Country (2019-2030)
- 10.3.2 South America Rapid-dissolving Tablets Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Rapid-dissolving Tablets Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Rapid-dissolving Tablets Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Rapid-dissolving Tablets Market Size by Country
- 11.3.1 Middle East & Africa Rapid-dissolving Tablets Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Rapid-dissolving Tablets Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Rapid-dissolving Tablets Market Drivers
- 12.2 Rapid-dissolving Tablets Market Restraints
- 12.3 Rapid-dissolving Tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Rapid-dissolving Tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Rapid-dissolving Tablets
- 13.3 Rapid-dissolving Tablets Production Process
- 13.4 Rapid-dissolving Tablets Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Rapid-dissolving Tablets Typical Distributors
- 14.3 Rapid-dissolving Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Rapid-dissolving Tablets. Industry analysis & Market Report on Rapid-dissolving Tablets is a syndicated market report, published as Global Rapid-dissolving Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Rapid-dissolving Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
